[ACRX] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
02-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -4.12%
YoY- -9.53%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 6,435 3,366 4,531 3,025 1,730 15,428 1,924 122.82%
PBT -9,682 -11,438 -11,092 -10,979 -10,558 5,841 -8,896 5.77%
Tax 68 -36 -2,083 2 -12 772 777 -80.14%
NP -9,682 -11,402 -11,092 -10,981 -10,546 5,069 -8,896 5.77%
Tax Rate - - - - - -13.22% - -
Total Cost 16,117 14,768 15,623 14,006 12,276 10,359 10,820 30.27%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin -150.46 -338.74 -244.80 -363.01 -609.60 32.86 -462.37 -52.52%
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -4.27 -5.03 -4.90 -4.85 -4.66 2.20 -4.01 4.25%
EPS Diluted -4.27 -5.03 -4.90 -4.85 -4.66 2.20 -4.01 4.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.